Financial Review: NAYA Biosciences (NASDAQ:NAYA) and Nemaura Medical (NASDAQ:NMRD)

NAYA Biosciences (NASDAQ:NAYA) and Nemaura Medical (NASDAQ:NMRD) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, dividends, institutional ownership and earnings.

Profitability

This table compares NAYA Biosciences and Nemaura Medical’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
NAYA Biosciences	-119.91%	N/A	-41.72%
Nemaura Medical	N/A	N/A	N/A

Valuation & Earnings

This table compares NAYA Biosciences and Nemaura Medical”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
NAYA Biosciences	$6.23 million	0.09	-$8.03 million	N/A	N/A
Nemaura Medical	$3,017.00	0.00	-$14.14 million	($0.39)	N/A

NAYA Biosciences has higher revenue and earnings than Nemaura Medical.

Volatility and Risk

NAYA Biosciences has a beta of 2.03, indicating that its share price is 103% more volatile than the S&P 500. Comparatively, Nemaura Medical has a beta of 0.5, indicating that its share price is 50% less volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of recent recommendations for NAYA Biosciences and Nemaura Medical, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NAYA Biosciences	0	0	1	0	3.00
Nemaura Medical	0	0	0	0	0.00

NAYA Biosciences currently has a consensus price target of $24.00, indicating a potential upside of 2,827.19%. Given NAYA Biosciences’ stronger consensus rating and higher probable upside, equities analysts plainly believe NAYA Biosciences is more favorable than Nemaura Medical.

Institutional and Insider Ownership

12.0% of NAYA Biosciences shares are held by institutional investors. Comparatively, 4.4% of Nemaura Medical shares are held by institutional investors. 1.8% of NAYA Biosciences shares are held by insiders. Comparatively, 40.4% of Nemaura Medical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Summary

NAYA Biosciences beats Nemaura Medical on 7 of the 10 factors compared between the two stocks.

About NAYA Biosciences

NAYA Biosciences is a life science portfolio company dedicated to bringing breakthrough treatments to patients in oncology, autoimmune diseases and fertility. NAYA Biosciences, formerly known as INVO BIOSCIENCE, is based in SARASOTA, Fla.

About Nemaura Medical

Nemaura Medical Inc., a medical technology company, manufactures continuous glucose monitoring system in the United States. It offers sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes, that provide prompts and educate users on factors affecting blood sugar profiles, as well as conducts diabetes prevention and reversal programs. Nemaura Medical Inc. was founded in 2009 and is based in New York, New York.